A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Summary

The purpose of this study is to find out whether the new drug PX-866 will slow the growth of your glioblastoma multiforme.

Timeline

Start

2011-04-01

Primary completion

2014-10-29

Completion

2015-02-13

Publications

• Results Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP. Phase II study of PX-866 in recurrent glioblastoma. Neuro Oncol. 2015 Sep;17(9):1270-4. doi: 10.1093/neuonc/nou365. Epub 2015 Jan 20.

Drugs

Indications